Tivic Health Systems Stock (NASDAQ:TIVC)

Revenue Ownership Financials Chart Transcripts

Previous Close

$2.99

52W Range

$2.43 - $15.64

50D Avg

$3.55

200D Avg

$4.35

Market Cap

$3.32M

Avg Vol (3M)

$1.01M

Beta

1.98

Div Yield

-

TIVC Company Profile

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

7

IPO Date

Nov 11, 2021

Website

TIVC Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 24	Dec 23	Dec 22
Shipping and Handling	$1.00K	$3.00K	$3.00K

Fiscal year ends in Dec 24 | Currency in USD

TIVC Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$780.00K	$1.18M	$1.84M
Operating Income	$-5.66M	$-8.24M	$-10.10M
Net Income	$-5.66M	$-8.24M	$-10.10M
EBITDA	$-5.66M	$-8.06M	$-9.92M
Basic EPS	$-0.02	$-4.16	$-104.37
Diluted EPS	$-0.02	$-4.16	$-104.37

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q2 25Aug 14, 25 | 4:30 PM

Q1 25May 15, 25 | 4:30 PM

Q4 24Mar 21, 25 | 4:30 PM

Peer Comparison

Ticker	Company
BBLG	Bone Biologics Corporation
NUWE	Nuwellis, Inc.
BJDX	Bluejay Diagnostics, Inc.
CNTX	Context Therapeutics Inc.
HSCS	HeartSciences Inc.